Introduction
Continuous ambulatory peritoneal dialysis (CAPD) patients using conventional glucose-containing dialysates (GD) reveal a high prevalence of hypokalemia [1] [2] [3] [4] . Spital et al. documented that 36% of all CAPD patients had hypokalemia, that about 20% of these patients received potassium (K + ) supplement, and for the correction of acute hypokalemia, a method using dialysate directly mixed with K + was very safe and effective 3) . Furthermore, in a recently reported Chinese study, hypokalemia, represented in 20.3%
of CAPD patients, could be an independent risk factor for their survival 5) .
7.5% icodextrin (ID), a new class of osmotic agents that
is an alternative non-glucose-containing dialysate, has now been proven to be clinically useful in the fluid management of peritoneal dialysis (PD) patients and has improved biocompatibility when compared to the traditional solutions [6] [7] [8] [9] . We evaluated differences in serum K + profiles and influencing factors related internal K + balance between GD and ID in stable CAPD patients, and additionally the safety and effectiveness of acute intraperitoneal K + load.
Subjects and Method

Subjects
We enrolled nine stable CAPD patients at Hanyang 
Result
Nine CAPD patients at our hospital were enrolled in this study. The causes of end stage renal disease (ESRD)
were type 2 diabetes mellitus (7/9) and chronic glomerulonephritis (2/9). The duration of CAPD was 6.9±6.4 The demographics of study population are shown in Table   Table 1 The basal levels of insulin (18.3±3.8 U/ml on GD vs. μ 19.1±4.3 U/ml on ID) were similar between the GD and μ ID groups. However, the insulin level, checked up after 2 hours' dwell, were 17.7±4.0 U/ml on ID vs. 30.9±6.0 μ U/mL on GD, thus the change from basal insulin levels μ was much lower on ID (-1.5±0.6 U/ml on ID vs. 12.6±2.6 μ U/mL on GD, p<0.05, Fig. 4 ). In seven diabetic CAPD μ patients, similar results were shown that the change from basal insulin was also lower on ID (-1.5±0.6 U/ml on μ ID vs. 11.1±3.1 U/mL on GD, p<0.05, Fig. 4) . μ
Changes of blood aldosterone, epinephrine, and osmolality from baseline levels were not significantly different through the 6-hr dwell in both regimens of GD and ID (Table 4) .
Complications following intraperitoneal K + load
All subjects did not complain any symptoms and signs and also their vital signs were stable after intraperitoneal K + (40 mEq, 20 mEq/L) load.
Discussion
Generally, K + homeostasis is controlled by external and internal K + balance. External K + balance is maintained between K + intake and excretion through the kidney and intestine. Internal K + balance is affected by K + redistribution between intracellular and extracellular spaces.
However, in ESRD, K + excretion through kidney reduces, thus, K + homeostasis is maintained by low K + diet, K + Fig. 4 . Comparison of changes in the plasma insulin levels between Icodextrin and 2.5% glucose solution at 2-hr dwell following intraperitoneal administration of potassium in CAPD patients (n=9). CAPD, continuous ambulatory peritoneal dialysis. 10, 11) . Theoretically it would not be enough to maintain a safe plasma K + level because daily K + intake is greater than daily K + removal through PD and excretion via the intestine 1, 10) . However, actually, in PD patients, normokalemia and mild hypokalemia are more frequent than hyperkalemia [1] [2] [3] [4] . Why does that phenomenon occur?
The answers are that K + moves in intracellular space as glucose containing dialysate stimulates insulin secretion and intracellular and intramuscular Kv levels are higher in PD patients than in HD patients 12) . 10) . A critical limitation of this study is that the size of our study population was not large enough to compare the difference between diabetic and nondiabetic PD patients, the result of seven diabetic PD patients in our study has shown that the increment of insulin was significantly higher in GD than ID, after K + load. Such results
represented that insulin, also in diabetic ESRD patients, could play a role to control internal K + balance.
As mentioned above, the long term use of high-glucose containing dialysate could provoke peritoneal damage and insulin secretion that causes hyperinsulinemia or atherosclerotic cardiovascular accidents 13) . On the other hand, ID, as iso-osmolar and starch-derived glucose polymer, reduces hyperinsulinemia, insulin resistance 13) , and glucose degradation product (GDP) which material causes the peritoneal damage by the stimulation of mesothelial cell apoptosis and oncosis in peritoneum 14) . One study reported that the long term use of ID does not cause weight gain and edema 15) . Thus ID is expected to substitute for GD in hypokalemic PD patients due to lower peritoneal damage and lower K + shift to intracellular space than GD.
In conclusion, we suggest that intraperitoneal K + load and using ID to substitute for GD, as the treatment for acute hypokalemia in CAPD patient, could be safe and effective methods because ID less stimulates insulin secretion than GD. K + homeostasis, in diabetic CAPD patients, could be well controlled without defects of internal K + balance, so called K + redistribution, in this study.
